Vincetoxicum pycnostelma CA-NHP Not yet graded
CA licensed ingredient
Market presence39 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-015314
Compound index — V
305 substances begin with V. 3 of them carry an Etalyn grade; the remainder are marked not yet graded, which is a statement about Etalyn’s coverage and not about the substance. This page shows 105 of them, Vincetoxicum pycnostelma – Vutrisiran.
US-DRUGListed as a marketed drug substance in the United StatesEU-MEDActive substance in a centrally authorised EU medicineEU-HERBSubject of an EU herbal monographUS-CSAScheduled under the US Controlled Substances ActCA-NHPLicensed supplement ingredient in CanadaEU-CLAIMAppears in the EU nutrition and health claims registerEU-NOVELAppears in the EU novel food catalogueETALYNEtalyn has graded a claim about this substance
Vincetoxicum stauntonii CA-NHP Not yet graded
CA licensed ingredient
Market presence30 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-015315
Vincristine Sulfate US-DRUG Not yet graded
US: anda
Class as recordedVinca Alkaloid [EPC]; Vinca Alkaloids [CS]
Earliest US approval1963
Market presence5 US product listings · 18 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-015316
Vinegar CA-NHP Not yet graded
CA licensed ingredient
Market presence1 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-015317
vinflunine EU-MED Not yet graded
EU medicine: Authorised
Class as recordedL01CA05
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-015318
Vinorelbine Tartrate US-DRUG Not yet graded
US: anda
Class as recordedVinca Alkaloid [EPC]; Vinca Alkaloids [CS]
Earliest US approval1994
Market presence6 US product listings · 12 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-015319
Vinpocetine CA-NHP Not yet graded
CA licensed ingredient
Market presence12 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-015320
Viola cornuta EU-NOVEL Not yet graded
Novel, not yet authorised
also: Mnemion cornutum Spach
Parts in scopeFlowers
Recorded fromEU-NOVEL — 1 of 7 registers
Etalyn identifierETA-C-015321
Viola Japonica Whole US-DRUG Not yet graded
US: unapproved homeopathic
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-015322
Viola Odorata CA-NHPUS-DRUG Not yet graded
CA licensed ingredientUS: drug for further processing
Class as recordedAllergens [CS]; Ammonium Ion Binding Activity [MoA]; Antimalarial [EPC]; Bee Venoms [CS]
Market presence20 US product listings · 47 Canadian licensed products
Etalyn identifierETA-C-015323
Viola Odorata Flower US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Dietary Proteins [CS]; Fruit Proteins [EXT]
Market presence4 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-015324
Viola Odorata Whole US-DRUG Not yet graded
US: drug for further processing
Class as recordedAdrenergic alpha-Agonists [MoA]; Adrenergic beta-Agonists [MoA]; Allergens [CS]; Antimalarial [EPC]
Market presence8 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-015325
Viola philippica var. philippica CA-NHP Not yet graded
CA licensed ingredient
Market presence60 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-015326
Viola Tricolor CA-NHPEU-NOVELUS-DRUG Not yet graded
Not novel in supplementsCA licensed ingredientUS: unapproved homeopathic
also: Jacea tricolor (L.) Opiz
Class as recordedAllergens [CS]; Bee Venoms [CS]; Cell-mediated Immunity [PE]; Copper Absorption Inhibitor [EPC]
Market presence14 US product listings · 28 Canadian licensed products
Parts in scopeAerial parts
Etalyn identifierETA-C-015327
Viola Tricolor Whole US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAdrenocorticotropic Hormone [CS]; Adrenocorticotropic Hormone [EPC]; Allergens [CS]; Cell-mediated Immunity [PE]
Market presence17 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-015328
Viola yedoensis CA-NHP Not yet graded
CA licensed ingredient
Market presence12 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-015329
Violae herba cum flore EU-HERB Not yet graded
Herbal monograph: F: Assessment finalised
also: Wild Pansy; Viola tricolor L.L.;Viola arvensis Murray (Gaud);Viola vulgaris Koch (Oborny)
Class as recordedherbal: Skin disorders and minor wounds
Recorded fromEU-HERB — 1 of 7 registers
Etalyn identifierETA-C-015330
Viomycin Sulfate US-DRUG Not yet graded
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-015331
Vipera CA-NHP Not yet graded
CA licensed ingredient
Market presence1 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-015332
Vipera berus CA-NHP Not yet graded
CA licensed ingredient
Market presence16 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-015333
Vipera Berus Venom US-DRUG Not yet graded
US: drug for further processing
Class as recordedAdrenergic alpha-Agonists [MoA]; Adrenergic beta-Agonists [MoA]; Allergens [CS]; Ammonium Ion Binding Activity [MoA]
Market presence32 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-015334
Vipera redi CA-NHP Not yet graded
CA licensed ingredient
Market presence3 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-015335
Vipera torva CA-NHP Not yet graded
CA licensed ingredient
Market presence5 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-015336
Vipivotide Tetraxetan US-DRUG Not yet graded
US: bulk ingredient
Market presence2 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-015337
viral protein 2 EU-MED Not yet graded
EU medicine: Authorised
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-015338
Virola Sebifera Resin US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedActively Acquired Immunity [PE]; Allergens [CS]; Bee Venoms [CS]; Blood Coagulation Factor [EPC]
Market presence24 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-015339
virus EU-MED Not yet graded
EU medicine: Authorised
Class as recordedJ07BD54
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-015340
Viscum album CA-NHPEU-HERBEU-NOVEL Not yet graded
Not novel in supplementsHerbal monograph: F: Assessment finalisedCA licensed ingredient
also: Mistletoe; Viscum albumL.; Common Mistletoe; Visci albi herba; European Mistletoe
Market presence85 Canadian licensed products
Parts in scopeLeaves and Stem; Infusion of the aerial parts
Etalyn identifierETA-C-015341
Viscum Album Fruit US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Bee Venoms [CS]; Cell-mediated Immunity [PE]; Dietary Proteins [CS]
Market presence4 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-015342
Viscum Album Fruiting TOP US-DRUG Not yet graded
US: drug for further processing
Class as recordedAdrenergic alpha-Agonists [MoA]; Adrenergic beta-Agonists [MoA]; Allergens [CS]; Allogeneic Cultured Cell Scaffold [EPC]
Market presence117 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-015343
Viscum Album Leaf US-DRUG Not yet graded
US: unapproved homeopathic
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-015344
Viscum Album Stem US-DRUG Not yet graded
US: unapproved homeopathic
Market presence4 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-015345
Viscum Album Subsp. Abietis Whole US-DRUG Not yet graded
US: unapproved homeopathic
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-015346
Viscum Album Whole US-DRUG Not yet graded
US: bulk ingredient
Class as recordedAllergens [CS]; Calculi Dissolution Agent [EPC]; Cell-mediated Immunity [PE]; Increased Histamine Release [PE]
Market presence26 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-015347
Viscum coloratum CA-NHP Not yet graded
CA licensed ingredient
Market presence7 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-015348
Vismodegib EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: bulk ingredient
Class as recordedHedgehog Pathway Inhibitor [EPC]; L01XX43; Smoothened Receptor Antagonists [MoA]
Earliest US approval2012
Market presence4 US product listings · 1 FDA applications · 1 EU medicines
Etalyn identifierETA-C-015349
Visnaga Daucoides Fruit US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Anticholinergic [EPC]; Calculi Dissolution Agent [EPC]; Cell-mediated Immunity [PE]
Market presence3 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-015350
vit D3 EU-CLAIM Not yet graded
EU claims 0 authorised / 1 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “Vitamin D3 has long been known to aid in calcium absorption, but new research shows that D3 also plays a role in cardiovascular function and supports healthy inflammatory response Vitamin D3 has long been known to aid in calcium absorption, but new resea” | Non-authorised | Art.13(1) | EFSA opinion |
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-015351
VitaGranate® Pomegranate Extract 40% Ellagic Acid EU-CLAIM Not yet graded
EU claims 0 authorised / 1 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “VitaGranate® Pomegranate Extract is an excellent source of pomegranate polyphenols, compounds that have been associated with the maintenance of cardiovascular health.” | Non-authorised | Art.13(1) | EFSA opinion |
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-015352
Vitamin A CA-NHPEU-CLAIMUS-DRUG Not yet graded
EU claims 6 authorised / 8 refusedCA licensed ingredientUS: bulk ingredient
Class as recordedAllergens [CS]; Analogs/Derivatives [Chemical/Ingredient]; Anti-Inflammatory Agents; Ascorbic Acid [CS]
Earliest US approval1947
Market presence94 US product listings · 46 FDA applications · 8,486 Canadian licensed products
Claims examined by the EU — wording reproduced, not Etalyn’s. 12 of 14 shown.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “Vitamin A contributes to normal iron metabolism” | Authorised | Art.13(1) | EFSA opinion |
| “Vitamin A contributes to the maintenance of normal mucous membranes” | Authorised | Art.13(1) | EFSA opinion |
| “Vitamin A contributes to the maintenance of normal skin” | Authorised | Art.13(1) | EFSA opinion |
| “Vitamin A contributes to the maintenance of normal vision” | Authorised | Art.13(1) | EFSA opinion |
| “Vitamin A contributes to the normal function of the immune system” | Authorised | Art.13(1) | EFSA opinion |
| “Vitamin A has a role in the process of cell specialisation” | Authorised | Art.13(1) | EFSA opinion |
| “Necessary for healthy teeth, bones, hair, skin and nails.” | Non-authorised | Art.13(1) | EFSA opinion |
| “Necessary for healthy teeth, bones, hair, skin and nails.” | Non-authorised | Art.13(1) | EFSA opinion |
| “Necessary for healthy teeth, bones, hair, skin and nails.” | Non-authorised | Art.13(1) | EFSA opinion |
| “Necessary for healthy teeth, bones, hair, skin and nails.” | Non-authorised | Art.13(1) | EFSA opinion |
| “Necessary to maintain energy and general vitality” | Non-authorised | Art.13(1) | EFSA opinion |
| “Vitamin A aids healthy bone and teeth growth.” | Non-authorised | Art.13(1) | EFSA opinion |
Etalyn identifierETA-C-015353
Vitamin A aldehyde CA-NHP Not yet graded
CA licensed ingredient
Market presence2 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-015354
Vitamin B1 CA-NHPEU-CLAIM Not yet graded
EU claims 0 authorised / 6 refusedCA licensed ingredient
Market presence59 Canadian licensed products
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “Necessary for healthy teeth, bones, hair, skin and nails.” | Non-authorised | Art.13(1) | EFSA opinion |
| “Necessary for healthy teeth, bones, hair, skin and nails.” | Non-authorised | Art.13(1) | EFSA opinion |
| “Necessary for healthy teeth, bones, hair, skin and nails.” | Non-authorised | Art.13(1) | EFSA opinion |
| “Necessary for healthy teeth, bones, hair, skin and nails.” | Non-authorised | Art.13(1) | EFSA opinion |
| “Necessary for healthy teeth, bones, hair, skin and nails.” | Non-authorised | Art.13(1) | EFSA opinion |
| “Necessary to maintain energy and general vitality” | Non-authorised | Art.13(1) | EFSA opinion |
Etalyn identifierETA-C-015355
Vitamin B12 CA-NHPEU-CLAIM Not yet graded
EU claims 8 authorised / 6 refusedCA licensed ingredient
Market presence13,446 Canadian licensed products
Claims examined by the EU — wording reproduced, not Etalyn’s. 12 of 14 shown.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “Vitamin B12 contributes to normal energy-yielding metabolism” | Authorised | Art.13(1) | EFSA opinion |
| “Vitamin B12 contributes to normal functioning of the nervous system” | Authorised | Art.13(1) | EFSA opinion |
| “Vitamin B12 contributes to normal homocysteine metabolism” | Authorised | Art.13(1) | EFSA opinion |
| “Vitamin B12 contributes to normal psychological function” | Authorised | Art.13(1) | EFSA opinion |
| “Vitamin B12 contributes to normal red blood cell formation” | Authorised | Art.13(1) | EFSA opinion |
| “Vitamin B12 contributes to the normal function of the immune system” | Authorised | Art.13(1) | EFSA opinion |
| “Vitamin B12 contributes to the reduction of tiredness and fatigue” | Authorised | Art.13(1) | EFSA opinion |
| “Vitamin B12 has a role in the process of cell division” | Authorised | Art.13(1) | EFSA opinion |
| “Necessary for healthy teeth, bones, hair, skin and nails” | Non-authorised | Art.13(1) | EFSA opinion |
| “Necessary for healthy teeth, bones, hair, skin and nails” | Non-authorised | Art.13(1) | EFSA opinion |
| “Necessary for healthy teeth, bones, hair, skin and nails” | Non-authorised | Art.13(1) | EFSA opinion |
| “Necessary for healthy teeth, bones, hair, skin and nails” | Non-authorised | Art.13(1) | EFSA opinion |
Etalyn identifierETA-C-015356
Vitamin B2 CA-NHPEU-CLAIM Not yet graded
EU claims 0 authorised / 5 refusedCA licensed ingredient
Market presence52 Canadian licensed products
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “- Riboflavin is needed/important for mental function and performance” | Non-authorised | Art.13(1) | EFSA opinion |
| “Necessary for healthy teeth, bones, hair, skin and nails.” | Non-authorised | Art.13(1) | EFSA opinion |
| “Necessary for healthy teeth, bones, hair, skin and nails.” | Non-authorised | Art.13(1) | EFSA opinion |
| “Necessary for healthy teeth, bones, hair, skin and nails.” | Non-authorised | Art.13(1) | EFSA opinion |
| “Necessary for healthy teeth, bones, hair, skin and nails.” | Non-authorised | Art.13(1) | EFSA opinion |
Etalyn identifierETA-C-015357
Vitamin B3 CA-NHPEU-CLAIM Not yet graded
EU claims 0 authorised / 4 refusedCA licensed ingredient
Market presence13 Canadian licensed products
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “Necessary for healthy teeth, bones, hair, skin and nails.” | Non-authorised | Art.13(1) | EFSA opinion |
| “Necessary for healthy teeth, bones, hair, skin and nails.” | Non-authorised | Art.13(1) | EFSA opinion |
| “Necessary for healthy teeth, bones, hair, skin and nails.” | Non-authorised | Art.13(1) | EFSA opinion |
| “Necessary for healthy teeth, bones, hair, skin and nails.” | Non-authorised | Art.13(1) | EFSA opinion |
Etalyn identifierETA-C-015358
Vitamin B5 CA-NHPEU-CLAIM Not yet graded
EU claims 0 authorised / 6 refusedCA licensed ingredient
Market presence7 Canadian licensed products
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “Necessary for healthy teeth, bones, hair, skin and nails.” | Non-authorised | Art.13(1) | EFSA opinion |
| “Necessary for healthy teeth, bones, hair, skin and nails.” | Non-authorised | Art.13(1) | EFSA opinion |
| “Necessary to maintain energy and general vitality” | Non-authorised | Art.13(1) | EFSA opinion |
| “Necessary for healthy teeth, bones, hair, skin and nails.” | Non-authorised | Art.13(1) | EFSA opinion |
| “Necessary for healthy teeth, bones, hair, skin and nails.” | Non-authorised | Art.13(1) | EFSA opinion |
| “Necessary for healthy teeth, bones, hair, skin and nails.” | Non-authorised | Art.13(1) | EFSA opinion |
Etalyn identifierETA-C-015359
Vitamin B6 CA-NHPEU-CLAIM Not yet graded
EU claims 10 authorised / 6 refusedCA licensed ingredient
Market presence13,875 Canadian licensed products
Claims examined by the EU — wording reproduced, not Etalyn’s. 12 of 16 shown.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “Vitamin B6 contributes to normal homocysteine metabolism” | Authorised | Art.13(1) | EFSA opinion |
| “Vitamin B6 contributes to normal protein and glycogen metabolism” | Authorised | Art.13(1) | EFSA opinion |
| “Vitamin B6 contributes to normal psychological function” | Authorised | Art.13(1) | EFSA opinion |
| “Vitamin B6 contributes to normal red blood cell formation” | Authorised | Art.13(1) | EFSA opinion |
| “Vitamin B6 contributes to the normal function of the immune system” | Authorised | Art.13(1) | EFSA opinion |
| “Vitamin B6 contributes to the reduction of tiredness and fatigue” | Authorised | Art.13(1) | EFSA opinion |
| “Vitamin B6 contributes to the regulation of hormonal activity” | Authorised | Art.13(1) | EFSA opinion |
| “Vitamin B6 contributes to normal cysteine synthesis” | Authorised | Art.13(1) | EFSA opinion |
| “Vitamin B6 contributes to normal energy-yielding metabolism” | Authorised | Art.13(1) | EFSA opinion |
| “Vitamin B6 contributes to normal functioning of the nervous system” | Authorised | Art.13(1) | EFSA opinion |
| “Necessary for healthy teeth, bones, hair, skin and nails.” | Non-authorised | Art.13(1) | EFSA opinion |
| “Necessary for healthy teeth, bones, hair, skin and nails.” | Non-authorised | Art.13(1) | EFSA opinion |
Etalyn identifierETA-C-015360
Vitamin C CA-NHPETALYNEU-CLAIM A/contestedband 4
EU claims 15 authorised / 4 refusedCA licensed ingredient
Market presence19,452 Canadian licensed products
Claims examined by the EU — wording reproduced, not Etalyn’s. 12 of 19 shown.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “Vitamin C contributes to maintain the normal function of the immune system during and after intense physical exercise” | Authorised | Art.13(1) | EFSA opinion |
| “Vitamin C contributes to normal collagen formation for the normal function of blood vessels” | Authorised | Art.13(1) | EFSA opinion |
| “Vitamin C contributes to normal collagen formation for the normal function of bones” | Authorised | Art.13(1) | EFSA opinion |
| “Vitamin C contributes to normal collagen formation for the normal function of cartilage” | Authorised | Art.13(1) | EFSA opinion |
| “Vitamin C contributes to normal collagen formation for the normal function of gums” | Authorised | Art.13(1) | EFSA opinion |
| “Vitamin C contributes to normal collagen formation for the normal function of skin” | Authorised | Art.13(1) | EFSA opinion |
| “Vitamin C contributes to normal collagen formation for the normal function of teeth” | Authorised | Art.13(1) | EFSA opinion |
| “Vitamin C contributes to normal energy-yielding metabolism” | Authorised | Art.13(1) | EFSA opinion |
| “Vitamin C contributes to normal functioning of the nervous system” | Authorised | Art.13(1) | EFSA opinion |
| “Vitamin C contributes to normal psychological function” | Authorised | Art.13(1) | EFSA opinion |
| “Vitamin C contributes to the normal function of the immune system” | Authorised | Art.13(1) | EFSA opinion |
| “Vitamin C contributes to the protection of cells from oxidative stress” | Authorised | Art.13(1) | EFSA opinion |
Etalyn identifierETA-C-015361
Vitamin D CA-NHPETALYNEU-CLAIMUS-DRUG B/contestedband 4
EU claims 10 authorised / 1 refusedCA licensed ingredientUS: bulk ingredient
Class as recordedAllergens [CS]; Analogs/Derivatives [Chemical/Ingredient]; Ascorbic Acid [CS]; Blood Coagulation Factor [EPC]
Market presence37 US product listings · 21,752 Canadian licensed products
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “Vitamin D is needed for normal growth and development of bone in children.” | Authorised | Art.14(1)(b) | EFSA opinion |
| “Vitamin D helps to reduce the risk of falling associated with postural instability and muscle weakness. Falling is a risk factor for bone fractures among men and women 60 years of age and older.” | Authorised | Art.14(1)(a) | EFSA opinion |
| “Vitamin D contributes to normal absorption/utilisation of calcium and phosphorus” | Authorised | Art.13(1) | EFSA opinion |
| “Vitamin D contributes to normal blood calcium levels” | Authorised | Art.13(1) | EFSA opinion |
| “Vitamin D contributes to the maintenance of normal bones” | Authorised | Art.13(1) | EFSA opinion |
| “Vitamin D contributes to the maintenance of normal muscle function” | Authorised | Art.13(1) | EFSA opinion |
| “Vitamin D contributes to the maintenance of normal teeth” | Authorised | Art.13(1) | EFSA opinion |
| “Vitamin D contributes to the normal function of the immune system” | Authorised | Art.13(1) | EFSA opinion |
| “Vitamin D has a role in the process of cell division” | Authorised | Art.13(1) | EFSA opinion |
| “Vitamin D is needed for the normal / proper function of the thyroid. Vitamin D is needed for the proper regulation of blood calcium levels.” | Non-authorised | Art.13(1) | EFSA opinion |
| “Vitamin D contributes to the normal function of the immune system in children.” | Authorised | Art.14(1)(b) | EFSA opinion |
Etalyn identifierETA-C-015362
Vitamin D2 CA-NHP Not yet graded
CA licensed ingredient
Market presence11 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-015363
Vitamin D3 CA-NHP Not yet graded
CA licensed ingredient
Market presence484 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-015364
Vitamin E CA-NHPEU-CLAIMUS-DRUG Not yet graded
EU claims 1 authorised / 15 refusedCA licensed ingredient
Earliest US approval1947
Market presence9 FDA applications · 14,211 Canadian licensed products
Claims examined by the EU — wording reproduced, not Etalyn’s. 12 of 16 shown.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “Vitamin E contributes to the protection of cells from oxidative stress” | Authorised | Art.13(1) | EFSA opinion |
| “Can neutralise free radicals and help maintain a healthy heart.” | Non-authorised | Art.13(1) | EFSA opinion |
| “Due to Vitamin E favourable effects on free radicals it could support reducing the age related cognitive decline.” | Non-authorised | Art.13(1) | EFSA opinion |
| “Helps memory and perception retention, especially in the elderly.” | Non-authorised | Art.13(1) | EFSA opinion |
| “Necessary for healthy teeth, bones, hair, skin and nails” | Non-authorised | Art.13(1) | EFSA opinion |
| “Necessary for healthy teeth, bones, hair, skin and nails” | Non-authorised | Art.13(1) | EFSA opinion |
| “Necessary for healthy teeth, bones, hair, skin and nails” | Non-authorised | Art.13(1) | EFSA opinion |
| “Necessary for healthy teeth, bones, hair, skin and nails” | Non-authorised | Art.13(1) | EFSA opinion |
| “Necessary for healthy teeth, bones, hair, skin and nails” | Non-authorised | Art.13(1) | EFSA opinion |
| “Necessary to maintain energy and general vitality” | Non-authorised | Art.13(1) | EFSA opinion |
| “Protects the lens.” | Non-authorised | Art.13(1) | EFSA opinion |
| “Regeneration of vitamin C” | Non-authorised | Art.13(1) | EFSA opinion |
Etalyn identifierETA-C-015365
Vitamin K EU-CLAIMUS-DRUG Not yet graded
EU claims 2 authorised / 0 refused
Earliest US approval2000
Market presence8 FDA applications
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “Vitamin K contributes to normal blood clotting” | Authorised | Art.13(1) | EFSA opinion |
| “Vitamin K contributes to the maintenance of normal bones” | Authorised | Art.13(1) | EFSA opinion |
Etalyn identifierETA-C-015366
Vitamin K1 CA-NHP Not yet graded
CA licensed ingredient
Market presence2,287 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-015367
Vitamin K1 + K2 EU-CLAIM Not yet graded
EU claims 0 authorised / 1 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “Vitamin K1 and K2 supports a healthy heart Vitamin K1 and K2 stimulates blood clotting.” | Non-authorised | Art.13(1) | EFSA opinion |
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-015368
Vitamin K2 CA-NHPEU-CLAIM Not yet graded
EU claims 0 authorised / 1 refusedCA licensed ingredient
Market presence2,451 Canadian licensed products
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “vitamin K2 contributes to vascular health.” | Non-authorised | Art.13(1) | EFSA opinion |
Etalyn identifierETA-C-015369
Vitamine B3 EU-CLAIM Not yet graded
EU claims 0 authorised / 2 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “Activate the scalp microcirculation” | Non-authorised | Art.13(1) | EFSA opinion |
| “Activate the scalp microcirculation” | Non-authorised | Art.13(1) | EFSA opinion |
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-015370
Vitamine B5 (Pantothenic acid) EU-CLAIM Not yet graded
EU claims 0 authorised / 1 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “Helps the skin hydration and fights against exfoliation. Helps to fight against skin dryness.” | Non-authorised | Art.13(1) | EFSA opinion |
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-015371
Vitamine B8 : Vitamin B8 or vitamin H (biotin) EU-CLAIM Not yet graded
EU claims 0 authorised / 1 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “Contribute to improve nail's resistance” | Non-authorised | Art.13(1) | EFSA opinion |
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-015372
Vitamine E and Sélénium EU-CLAIM Not yet graded
EU claims 0 authorised / 1 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “protect fatty acids of skin cell membranes from oxidation after sun exposure” | Non-authorised | Art.13(1) | EFSA opinion |
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-015373
Vitamins, minerals, lysine and/or arginine and/or taurine (Pharmaton Kiddi) EU-CLAIM Not yet graded
EU claims 0 authorised / 3 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “It helps to support an adequate vitamins/minerals/lysine supplementation in children, in case of unbalanced or insufficient nutrition To support a healthy growth and development in children. When a child is recovering from illness, or has a loss of appetite.” | Non-authorised | Art.13(1) | EFSA opinion |
| “When a child is recovering from illness, or has a loss of appetite, Pharmaton Kiddi provides important vitamins, minerals. These are important for developing and supporting proper immune system functions.” | Non-authorised | Art.13(1) | EFSA opinion |
| “scientifically proven to support attention and mental performance” | Non-authorised | Art.13(1) | EFSA opinion |
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-015374
Vitellaria paradoxa EU-NOVEL Not yet graded
Not novel in food
Parts in scopeshea butter; Polyphenol-rich extract
Recorded fromEU-NOVEL — 1 of 7 registers
Etalyn identifierETA-C-015375
Vitex agnus-castus CA-NHP Not yet graded
CA licensed ingredient
Market presence814 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-015376
Vitex negundo CA-NHP Not yet graded
CA licensed ingredient
Market presence12 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-015377
Vitex Negundo Fruit US-DRUG Not yet graded
US: unapproved homeopathic
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-015378
Vitex negundo L. var cannabifolia CA-NHP Not yet graded
CA licensed ingredient
Market presence1 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-015379
Vitex negundo Linn. EU-NOVEL Not yet graded
Novel, not yet authorised
also: Lagundi
Parts in scopeWhole
Recorded fromEU-NOVEL — 1 of 7 registers
Etalyn identifierETA-C-015380
Vitex rotundifolia CA-NHP Not yet graded
CA licensed ingredient
Market presence84 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-015381
Vitex trifolia CA-NHP Not yet graded
CA licensed ingredient
Market presence54 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-015382
Vitis labrusca CA-NHP Not yet graded
CA licensed ingredient
Market presence30 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-015383
Vitis rotundifolia CA-NHP Not yet graded
CA licensed ingredient
Market presence23 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-015384
Vitis vinifera CA-NHPEU-NOVEL Not yet graded
Not novel in foodCA licensed ingredient
Market presence2,384 Canadian licensed products
Parts in scopeFruits and unripe fruits (botanically berries), leaves, grape seed meal/flour/powder, and grape seeds oil; The bud, essential oil and grape seed extract with 65 % up to 95 % OPC; Free fatty acids from grape seed oil obtained by enzymatic process
Etalyn identifierETA-C-015385
Vitis Vinifera (Grape) Fruit Extract CA-NHP Not yet graded
CA licensed ingredient
Market presence1 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-015387
Vitis Vinifera (grape) Seed Oil US-DRUG Not yet graded
US: otc monograph drug
Market presence2 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-015392
Vitis Vinifera Flowering TOP US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Dietary Proteins [CS]; Fruit Proteins [EXT]
Market presence12 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-015386
Vitis vinifera L. CA-NHP Not yet graded
CA licensed ingredient
Market presence402 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-015388
Vitis vinifera L. seeds extract EU-CLAIM Not yet graded
EU claims 0 authorised / 3 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “Contributes to promote venous circulation in the legs” | Non-authorised | Art.13(5) | EFSA opinion |
| “Helps to drain the body in case of water accumulation” | Non-authorised | Art.13(5) | EFSA opinion |
| “Helps to decrease swollen legs” | Non-authorised | Art.13(5) | EFSA opinion |
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-005610
Vitis Vinifera Leaf US-DRUG Not yet graded
US: unapproved homeopathic
Market presence2 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-015389
Vitis Vinifera Seed US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAcidifying Activity [MoA]; Anti-coagulant [EPC]; Calcium Chelating Activity [MoA]; Calculi Dissolution Agent [EPC]
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-015390
Vitis vinifera var. tinctoria CA-NHP Not yet graded
CA licensed ingredient
Market presence14 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-015393
Vitis Vinifera Whole US-DRUG Not yet graded
US: unapproved homeopathic
Market presence3 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-015394
Vitis vinifera-flos CA-NHP Not yet graded
CA licensed ingredient
Market presence4 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-015395
Vitis viniferae folium EU-HERB Not yet graded
Herbal monograph: C: ongoing call for scientific data
also: Grapevine Leaf; Vitis viniferaL.
Class as recordedherbal: Circulatory disorders
Recorded fromEU-HERB — 1 of 7 registers
Etalyn identifierETA-C-015396
Vladimiria Soulei CA-NHP Not yet graded
CA licensed ingredient
Market presence2 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-015397
Voclosporin EU-MEDUS-DRUG Not yet graded
volanesorsen sodium EU-MED Not yet graded
EU medicine: Authorised
Class as recordedC10AX18
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-015399
Volvariella volvacea EU-NOVEL Not yet graded
Not novel in food
also: straw mushroom; Paddy straw mushroom; Agaricus volvaceus Bull., Volvaria volvacea (Bull.) P. Kumm., Volvariopsis volvacea (Bull.) Murrill, Agaricus virgatus Pers.
Parts in scopeFruiting body
Recorded fromEU-NOVEL — 1 of 7 registers
Etalyn identifierETA-C-015400
VON Willebrand Factor Human US-DRUG Not yet graded
US: bla
Class as recordedBlood Coagulation Factors [CS]; Factor VIII [CS]; Human Antihemophilic Factor [EPC]; Human Blood Coagulation Factor [EPC]
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-015401
vonicog alfa EU-MED Not yet graded
EU medicine: Authorised
Class as recordedB02BD10
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-015402
Vonoprazan US-DRUG Not yet graded
US: bulk ingredient
Earliest US approval2022
Market presence11 US product listings · 4 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-015403
Vorasidenib EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: nda
Class as recordedCytochrome P450 3A Inducers [MoA]; Isocitrate Dehydrogenase 1 Inhibitor [EPC]; Isocitrate Dehydrogenase 1 Inhibitors [MoA]; Isocitrate Dehydrogenase 2 Inhibitor [EPC]
Earliest US approval2024
Market presence2 US product listings · 1 FDA applications · 1 EU medicines
Etalyn identifierETA-C-015405
voretigene neparvovec EU-MED Not yet graded
EU medicine: Authorised
Class as recordedS01XA27
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-015406
Voriconazole EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: anda
Class as recordedAzole Antifungal [EPC]; Azoles [CS]; Cytochrome P450 2C19 Inhibitors [MoA]; Cytochrome P450 2C9 Inhibitors [MoA]
Earliest US approval2002
Market presence81 US product listings · 34 FDA applications · 3 EU medicines
Etalyn identifierETA-C-015407
Vorinostat EU-MEDUS-DRUG Not yet graded
EU medicine: Application withdrawnUS: bulk ingredient
Class as recordedHistone Deacetylase Inhibitor [EPC]; Histone Deacetylase Inhibitors [MoA]
Earliest US approval2006
Market presence4 US product listings · 1 FDA applications · 1 EU medicines
Etalyn identifierETA-C-015408
vosaroxin EU-MED Not yet graded
EU medicine: Application withdrawn
Class as recordedL01
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-015410
votumumab EU-MED Not yet graded
EU medicine: Withdrawn
Class as recordedV09IX
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-015412
Voxelotor EU-MEDUS-DRUG Not yet graded
EU medicine: SuspendedUS: bulk ingredient
Class as recordedB06AX03; Cytochrome P450 3A4 Inhibitors [MoA]; Hemoglobin S Polymerization Inhibitor [EPC]; Hemoglobin S Polymerization Inhibitors [MoA]
Earliest US approval2019
Market presence12 US product listings · 2 FDA applications · 1 EU medicines
Etalyn identifierETA-C-015413
voxilaprevi EU-MED Not yet graded
EU medicine: Authorised
Class as recordedJ05A
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-015414
Voxilaprevir US-DRUG Not yet graded
US: bulk ingredient
Class as recordedBreast Cancer Resistance Protein Inhibitors [MoA]; HCV NS3/4A Protease Inhibitors [MoA]; Hepatitis C Virus NS3/4A Protease Inhibitor [EPC]; Hepatitis C Virus NS5A Inhibitor [EPC]
Earliest US approval2017
Market presence3 US product listings · 1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-015415
VP2 protein EU-MED Not yet graded
EU medicine: Authorised
Market presence2 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-015416
Vutrisiran EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: bulk ingredient
Class as recordedDecreased RNA Integrity [PE]; Increased Protein Breakdown [PE]; N07XX18; RNA
Earliest US approval2022
Market presence2 US product listings · 1 FDA applications · 1 EU medicines
Etalyn identifierETA-C-015417